New research gives hope of an improved life quality for people suffering from motor complications due to Parkinson’s disease, Medtronic writes in a press release. The Medtech giant’s Deep Brain Stimulation (DBS) treatment formed the basis of the new study. The technique sees doctors using an implant similar to a pacemaker to transfer mild electrical impulses to specific areas of the brain, the company explains.
The clinical trial included 251 people with Parkinson’s disease at 17 centers in Germany and France and followed them over the course of two years. The results of the clinical trial was published in the latest issue of The New England Journal of Medicine.